Some studies show the overexpression of TDO in human hepatocellular carcinoma patient tissues that drives cell growth, migration, invasion, and epithelial to mesenchymal transition (EMT) via the AhR pathway (56). This evidence concerns the gene AHR and hepatocellular carcinoma.